Axovant Sciences Announces Presentation Time Change at Oppenheimer Healthcare Conference
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: PR Newswire
BASEL, Switzerland, March 20, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced a change to the company's presentation time at the Oppenheimer 27th Annual Healthcare Conference. Axovant will now present at 9:10 a.m. on Wednesday, March 22. A simultaneous webcast will be available for the conference in the Investors section of Axovant's website at www.axovant.com. A replay will be available for 30 days following the conference.About Axovant SciencesAxovant Sciences is a leading clinical-stage biopharmaceutical company focused on acquiring, developing and commercializing novel therapeutics for the treatment of dementia. Axovant intends to develop a pipeline of product candidates to comprehensively address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. Our vision is to become the leading company focused on the treatment of dementia b
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Axon Enterprise, Inc. (NASDAQ: AXON) had its price target raised by analysts at Barclays PLC from $308.00 to $381.00. They now have an "overweight" rating on the stock.MarketBeat
- Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It? [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]Yahoo! Finance
- Why Axon Enterprise Stock Dipped Today [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise (AXON) Q1 Earnings & Revenues Top Estimates [Yahoo! Finance]Yahoo! Finance
AXON
Earnings
- 5/6/24 - Beat
AXON
Sec Filings
- 5/9/24 - Form 144
- 5/9/24 - Form 144
- 5/9/24 - Form 144
- AXON's page on the SEC website